AllianceBernstein’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History

AllianceBernstein’s Portfolio OYST Stock Details OYST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-14,900	Closed	-$173K	–	3448
2022 Q1	$173K	Hold	14,900	–	–	﹤0.01%	3022
2021 Q4	$272K	Hold	14,900	–	–	﹤0.01%	2977
2021 Q3	$177K	Hold	14,900	–	–	﹤0.01%	3111
2021 Q2	$256K	Buy	14,900 +1,200	+9%	+$22.8K	﹤0.01%	3075
2021 Q1	$250K	Sell	13,700 -1,000	-7%	-$21K	﹤0.01%	2977
2020 Q4	$277K	Buy	14,700 +1,400	+11%	+$30.2K	﹤0.01%	2893
2020 Q3	$281K	Sell	13,300 -800	-6%	-$18.7K	﹤0.01%	2842
2020 Q2	$407K	Buy	+14,100	New	+$425K	﹤0.01%	2736

Other funds holding OYST

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

IFA

Invus Financial Advisors New York $89.2M AUM 10.79% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

TAM

Telemark Asset Management Boston, Massachusetts $1.08B AUM 70.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

AllianceBernstein's OYST Position: Q2 2022 in Review

AllianceBernstein sold out of Oyster Point Pharma, Inc. Common Stock (OYST) in Q2 2022, closing a stake of 14,900 shares — an estimated $173K sold.

AllianceBernstein first reported a position in OYST in Q2 2020 and held it in 8 quarters. The position peaked at $407K in Q2 2020. 61 funds tracked by Wall St. Rank hold OYST as of Q2 2022.

AllianceBernstein reported no remaining Oyster Point Pharma, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
AllianceBernstein sold 14,900 Oyster Point Pharma, Inc. Common Stock shares in Q2 2022, an estimated $173K.
AllianceBernstein first reported a position in Oyster Point Pharma, Inc. Common Stock in Q2 2020 and held it in 8 quarters.
AllianceBernstein's Oyster Point Pharma, Inc. Common Stock position peaked at $407K in Q2 2020.
61 funds tracked by Wall St. Rank held Oyster Point Pharma, Inc. Common Stock as of Q2 2022.

Based on AllianceBernstein's 13F filing for Q2 2022, filed 15 Aug 2022.